Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 627 results from 1 sources
https://web.expasy.org/cellosaurus/CVCL_M569

Cite this: (RRID:CVCL_M569)
Organism: Homo sapiens
Disease: Gastric carcinoma
Category: Cancer cell line
Comment: Doubling time: 31.4 hours, at 30th passage (PubMed=1888706). Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_M570

Cite this: (RRID:CVCL_M570)
Organism: Homo sapiens
Disease: Gastric carcinoma
Category: Cancer cell line
Comment: From: Yanoma S.; School of Medicine; Yokohama City University; Yokohama; Japan.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_M810

Cite this: (RRID:CVCL_M810)
Organism: Homo sapiens
Disease:
Category: Transformed cell line
Comment: Transfected with: HGNC; 5173; HRAS (with p.Gln61Leu). Transformant: NCIt; C129640; Cobalt-60 gamma radiation.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_S982

Cite this: (JCRB Cat# JCRB0077, RRID:CVCL_S982)
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: COSMIC cell lines project. From: Immuno-Biological Laboratories (IBL); Tokyo; Japan. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: SNP array analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (CLS Cat# 300356/p804_THP-1, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_1704

Cite this: (JCRB Cat# JCRB0232, RRID:CVCL_1704)
Organism: Homo sapiens
Disease: Human papillomavirus-related cervical squamous cell carcinoma
Category: Cancer cell line
Comment: Part of: COSMIC cell lines project. Microsatellite instability: Stable (MSS) (Sanger). Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16). Omics: Deep exome analysis. Omics: DNA methylation analysis. Omics: Transcriptome analysis.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0001

Cite this: (KCB Cat# KCB 200808YJ, RRID:CVCL_0001)
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (c.1849G>T) (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0001

Cite this: (JCRB Cat# JCRB0062, RRID:CVCL_0001)
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (c.1849G>T) (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0001

Cite this: (DSMZ Cat# ACC-11, RRID:CVCL_0001)
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (c.1849G>T) (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0001

Cite this: (Coriell Cat# GM06141, RRID:CVCL_0001)
Organism: Homo sapiens
Disease: Erythroleukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Doubling time: ~24 hours (PubMed=6177045); ~36 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Homozygous for JAK2 p.Val617Phe (c.1849G>T) (PubMed=16408098). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (RCB Cat# RCB3686, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (ICLC Cat# HTL97014, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (NIH-ARP Cat# 9942-142, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (CCLV Cat# CCLV-RIE 0439, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (ECACC Cat# 88081201, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (TKG Cat# TKG 0210, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0006

Cite this: (NCBI_Iran Cat# C563, RRID:CVCL_0006)
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC); p.Gly12Ser according to PubMed=9379676. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (DSMZ Cat# ACC-10, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (IZSLER Cat# BS TCL 33, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

https://web.expasy.org/cellosaurus/CVCL_0004

Cite this: (RCB Cat# RCB1897, RRID:CVCL_0004)
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: COSMIC cell lines project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI-60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Array-based CGH. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: Genome sequenced. Omics: H3K27ac ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me1 ChIP-seq epigenome analysis. Omics: H3K4me2 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K79me2 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: H3K9me1 ChIP-seq epigenome analysis. Omics: H3K9me3 ChIP-seq epigenome analysis. Omics: H4K20me1 ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: K-652; In Cosmic 1523829. Misspelling: K652; In Cosmic 1516632 and Cosmic 2024372. Derived from sampling site: Pleural effusion.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X